Merilin Al Sharif

Molecular Modelling Study of the PPARγ Receptor in Relation to the Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis

Ivanka Tsakovska, Merilin Al Sharif, Petko Alov et al. · International Journal of Molecular Sciences · 2014 · 39 citations · Full text

Immunology, Liver Steatosis, Pparγ Full Agonists +29

The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation

Merilin Al Sharif, Ivanka Tsakovska, Ilza Pajeva et al. · Toxicology · 2016 · 22 citations · Full text

Chemical Safety, Engineering, Pharmacokinetic Modeling +11

Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists

F. Fratev, Ivanka Tsakovska, Merilin Al Sharif et al. · International Journal of Molecular Sciences · 2015 · 17 citations · Full text

Molecular Biology, Pharmacotherapy, Molecular Dynamics +26

Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction

Merilin Al Sharif, Petko Alov, Vessela Vitcheva et al. · Toxicology and Applied Pharmacology · 2017 · 14 citations

Metabolic Syndrome, Hepatology, Medicine +13

Molecular determinants of PPARγ partial agonism and related in silico/in vivo studies of natural saponins as potential type 2 diabetes modulators

Merilin Al Sharif, Petko Alov, Antonia Diukendjieva et al. · Food and Chemical Toxicology · 2017 · 14 citations

Natural Saponins, Molecular Pharmacology, Metabolic Syndrome +15